StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by scarri101on Jul 23, 2020 11:43am

65 Views

Post# 31308016

RE:RE:RE:Q2 date ?

Jonnyboy85 wrote: The best part is Scarri is also very outspoken about our company, while doing absolutely no research apparently

Str8Shuter wrote: Does nobody do even the most basic DD anymore these days? Pretty sure I would be rather embarrassed to ask that Q2 date question instead of just attempting to look it up for myself. Just sayin.

scarri101 wrote: I know it's been answeredd.. mid August ?? Can we expect some momentum in the net week or so ??